• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo

Applying the Organage Proteomic Clock to Old Blood Samples to Assess Predictive Ability


  • Please log in to reply
No replies to this topic

#1 reason

  • Guardian Reason
  • 1,101 posts
  • 298
  • Location:US

Posted Yesterday, 10:22 AM


Repositories of well-characterized 20+ year old stored blood samples that can be accessed for analysis are few and far between. Here, researchers make use of one such resource to characterize a proteomic aging clock for its ability to predict future health outcomes. This clock, organage, assesses a biological age for different organs based on levels of circulating proteins specifically produced by each organ. As one might expect, people who later developed an age-related dysfunction of an organ and consequent disease tended towards a higher biological age for that organ in the late 1990s, as measured by organage.

In this observational cohort study, to assess the biological age of an individual's organs relative to those of same-aged peers, ie, organ age gaps, we collected plasma samples from 6235 middle-aged (age 45-69 years) participants of the Whitehall II prospective cohort study in London, UK, in 1997-99. Age gaps of nine organs were determined from plasma proteins. Following this assessment, we tracked participants for 20 years through linkage to national health records. Study outcomes were 45 individual age-related diseases and multimorbidity.

Over 123,712 person-years of observation (mean follow-up 19.8 years), after excluding baseline disease cases and adjusting for age, sex, ethnicity, and age gaps in organs other than the one under investigation, individuals with large organ age gaps showed an increased risk of 30 diseases. Six diseases were exclusively associated with accelerated ageing of their respective organ: liver failure (hazard ratio   per standard deviation increment in the organ age gap 2.13), dilated cardiomyopathy (HR 1.65), chronic heart failure (HR 1.52), lung cancer (HR 1.29), agranulocytosis (HR 1.27), and lymphatic node metastasis (HR 1.23). 24 diseases were associated with more than one organ age gap or with organ age gaps not directly related to the disease location. Larger age gaps were also associated with elevated HRs of developing two or more diseases affecting different organs within the same individual (ie, multiorgan multimorbidity): 2.03 for the arterial age gap, 1.78 for the kidney age gap, 1.52 for the heart age gap, 1.52 for the brain age gap, 1.43 for the pancreas age gap, 1.37 for the lung age gap, 1.36 for the immune system age gap, and 1.30 for the liver age gap.

Link: https://doi.org/10.1016/j.landig.2025.01.006


View the full article at FightAging




1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users